Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms

Neuroscience and Biobehavioral Reviews

Volumn 46, Issue P2, 2014, Pages 161-174

  Srivastava, Anand K ^a   Schwartz, Charles E ^a  

^a GREENWOOD GENETIC CENTER   (United States)

Author keywords

Autism spectrum disorders; Intellectual disability; Molecular pathways; Neurodevelopmental disorder; Synaptic plasticity

Indexed keywords

CELL ADHESION MOLECULE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SYNAPSIN; UBIQUITIN; NERVE CELL ADHESION MOLECULE;

ACTIN POLYMERIZATION; ASPERGER SYNDROME; AUTISM; COGNITIVE DEFECT; COPY NUMBER VARIATION; DENDRITIC SPINE; EXOCYTOSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; HAPPY PUPPET SYNDROME; HUMAN; HUMAN GENOME; INTELLECTUAL IMPAIRMENT; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW; SYNAPSE VESICLE; SYNAPTOGENESIS; SYNAPTOSOME; TRANSLATION REGULATION; X CHROMOSOME; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; CYTOSKELETON; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CYTOSKELETON; HUMANS; INTELLECTUAL DISABILITY; MODELS, NEUROLOGICAL; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; SYNAPTIC VESICLES;

EID: 84909602568     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.02.015     Document Type: Review

References (201)

1. Abou Jamra R., Philippe O., Raas-Rothschild A., Eck S.H., Graf E., Buchert R., Borck G., Ekici A., Brockschmidt F.F., Nothen M.M., Munnich A., Strom T.M., Reis A., Colleaux L. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am. J. Hum. Genet. 2011, 88:788-795.
2. Addington A.M., Gauthier J., Piton A., Hamdan F.F., Raymond A., Gogtay N., Miller R., Tossell J., Bakalar J., Inoff-Germain G., Gochman P., Long R., Rapoport J.L., Rouleau G.A. A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders. Mol. Psychiatry 2011, 16:238-239.
3. Allen K.M., Gleeson J.G., Bagrodia S., Partington M.W., MacMillan J.C., Cerione R.A., Mulley J.C., Walsh C.A. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 1998, 20:25-30.
4. American Psychiatric Association Diagnostic Criteria From DSM-IV-TR 2000, American Psychiatric Association, Washington, DC.
5. Anney R., Klei L., Pinto D., Almeida J., Bacchelli E., Baird G., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Casey J., Conroy J., Correia C., Corsello C., Crawford E.L., de Jonge M., Delorme R., Duketis E., Duque F., Estes A., Farrar P., Fernandez B.A., Folstein S.E., Fombonne E., Gilbert J., Gillberg C., Glessner J.T., Green A., Green J., Guter S.J., Heron E.A., Holt R., Howe J.L., Hughes G., Hus V., Igliozzi R., Jacob S., Kenny G.P., Kim C., Kolevzon A., Kustanovich V., Lajonchere C.M., Lamb J.A., Law-Smith M., Leboyer M., Le Couteur A., Leventhal B.L., Liu X.Q., Lombard F., Lord C., Lotspeich L., Lund S.C., Magalhaes T.R., Mantoulan C., McDougle C.J., Melhem N.M., Merikangas A., Minshew N.J., Mirza G.K., Munson J., Noakes C., Nygren G., Papanikolaou K., Pagnamenta A.T., Parrini B., Paton T., Pickles A., Posey D.J., Poustka F., Ragoussis J., Regan R., Roberts W., Roeder K., Roge B., Rutter M.L., Schlitt S., Shah N., Sheffield V.C., Soorya L., Sousa I., Stoppioni V., Sykes N., Tancredi R., Thompson A.P., Thomson S., Tryfon A., Tsiantis J., Van Engeland H., Vincent J.B., Volkmar F., Vorstman J.A., Wallace S., Wing K., Wittemeyer K., Wood S., Zurawiecki D., Zwaigenbaum L., Bailey A.J., Battaglia A., Cantor R.M., Coon H., Cuccaro M.L., Dawson G., Ennis S., Freitag C.M., Geschwind D.H., Haines J.L., Klauck S.M., McMahon W.M., Maestrini E., Miller J., Monaco A.P., Nelson S.F., Nurnberger J.I., Oliveira G., Parr J.R., Pericak-Vance M.A., Piven J., Schellenberg G.D., Scherer S.W., Vicente A.M., Wassink T.H., Wijsman E.M., Betancur C., Buxbaum J.D., Cook E.H., Gallagher L., Gill M., Hallmayer J., Paterson A.D., Sutcliffe J.S., Szatmari P., Vieland V.J., Hakonarson H., Devlin B. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 2012, 21:4781-4792.
6. Arber S., Barbayannis F.A., Hanser H., Schneider C., Stanyon C.A., Bernard O., Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998, 393:805-809.
7. Arons M.H., Thynne C.J., Grabrucker A.M., Li D., Schoen M., Cheyne J.E., Boeckers T.M., Montgomery J.M., Garner C.C. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J. Neurosci. 2012, 32:14966-14978.
8. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
9. Ba W., van der Raadt J., Nadif Kasri N. Rho GTPase signaling at the synapse: Implications for intellectual disability. Exp. Cell Res. 2013, 319:2368-2374.
10. Badura-Stronka M., Jamsheer A., Materna-Kiryluk A., Sowinska A., Kiryluk K., Budny B., Latos-Bielenska A. A novel nonsense mutation in CUL4B gene in three brothers with X-linked mental retardation syndrome. Clin. Genet. 2010, 77:141-144.
11. Bahi N., Friocourt G., Carrie A., Graham M.E., Weiss J.L., Chafey P., Fauchereau F., Burgoyne R.D., Chelly J. IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum. Mol. Genet. 2003, 12:1415-1425.
12. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M., Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 2008, 82:165-173.
13. Baldelli P., Fassio A., Valtorta F., Benfenati F. Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J. Neurosci. 2007, 27:13520-13531.
14. Basel-Vanagaite L., Dallapiccola B., Ramirez-Solis R., Segref A., Thiele H., Edwards A., Arends M.J., Miro X., White J.K., Desir J., Abramowicz M., Dentici M.L., Lepri F., Hofmann K., Har-Zahav A., Ryder E., Karp N.A., Estabel J., Gerdin A.K., Podrini C., Ingham N.J., Altmuller J., Nurnberg G., Frommolt P., Abdelhak S., Pasmanik-Chor M., Konen O., Kelley R.I., Shohat M., Nurnberg P., Flint J., Steel K.P., Hoppe T., Kubisch C., Adams D.J., Borck G. Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome. Am. J. Hum. Genet. 2012, 91:998-1010.
15. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., Mobley W.C. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J. Comp. Neurol. 2004, 480:281-298.
16. Ben-David E., Shifman S. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS Genet. 2012, 8:e1002556.
17. Berkel S., Marshall C.R., Weiss B., Howe J., Roeth R., Moog U., Endris V., Roberts W., Szatmari P., Pinto D., Bonin M., Riess A., Engels H., Sprengel R., Scherer S.W., Rappold G.A. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 2010, 42:489-491.
18. Betancur C., Sakurai T., Buxbaum J.D. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci. 2009, 32:402-412.
19. Bhalla K., Luo Y., Buchan T., Beachem M.A., Guzauskas G.F., Ladd S., Bratcher S.J., Schroer R.J., Balsamo J., DuPont B.R., Lilien J., Srivastava A.K. Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability. Am. J. Hum. Genet. 2008, 83:703-713.
20. Bhat S.S., Ladd S., Grass F., Spence J.E., Brasington C.K., Simensen R.J., Schwartz C.E., Dupont B.R., Stevenson R.E., Srivastava A.K. Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism. Clin. Genet. 2008, 73:94-96.
21. Bianchi V., Farisello P., Baldelli P., Meskenaite V., Milanese M., Vecellio M., Muhlemann S., Lipp H.P., Bonanno G., Benfenati F., Toniolo D., D'Adamo P. Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. Hum. Mol. Genet. 2009, 18:105-117.
22. Bianchi V., Gambino F., Muzio L., Toniolo D., Humeau Y., D'Adamo P. Forebrain deletion of alphaGDI in adult mice worsens the pre-synaptic deficit at cortico-lateral amygdala synaptic connections. PLoS ONE 2012, 7:e29763.
23. Bingol B., Schuman E.M. Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 2006, 441:1144-1148.
24. Blanpied T.A., Ehlers M.D. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol. Psychiatry 2004, 55:1121-1127.
25. Boda B., Alberi S., Nikonenko I., Node-Langlois R., Jourdain P., Moosmayer M., Parisi-Jourdain L., Muller D. The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J. Neurosci. 2004, 24:10816-10825.
26. Bourne J.N., Harris K.M. Balancing structure and function at hippocampal dendritic spines. Annu. Rev. Neurosci. 2008, 31:47-67.
27. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., Alvarez Retuerto A.I., Imielinski M., Hadley D., Bradfield J.P., Kim C., Gidaya N.B., Lindquist I., Hutman T., Sigman M., Kustanovich V., Lajonchere C.M., Singleton A., Kim J., Wassink T.H., McMahon W.M., Owley T., Sweeney J.A., Coon H., Nurnberger J.I., Li M., Cantor R.M., Minshew N.J., Sutcliffe J.S., Cook E.H., Dawson G., Buxbaum J.D., Grant S.F., Schellenberg G.D., Geschwind D.H., Hakonarson H. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009, 5:e1000536.
28. Budny B., Badura-Stronka M., Materna-Kiryluk A., Tzschach A., Raynaud M., Latos-Bielenska A., Ropers H.H. Novel missense mutations in the ubiquitination-related gene UBE2A cause a recognizable X-linked mental retardation syndrome. Clin. Genet. 2010, 77:541-551.
29. Cajigas I.J., Will T., Schuman E.M. Protein homeostasis and synaptic plasticity. EMBO J. 2010, 29:2746-2752.
30. Cao C., Rioult-Pedotti M.S., Migani P., Yu C.J., Tiwari R., Parang K., Spaller M.R., Goebel D.J., Marshall J. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 2013, 11:e1001478.
31. Carrie A., Jun L., Bienvenu T., Vinet M.C., McDonell N., Couvert P., Zemni R., Cardona A., Van Buggenhout G., Frints S., Hamel B., Moraine C., Ropers H.H., Strom T., Howell G.R., Whittaker A., Ross M.T., Kahn A., Fryns J.P., Beldjord C., Marynen P., Chelly J. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 1999, 23:25-31.
32. Cesca F., Baldelli P., Valtorta F., Benfenati F. The synapsins: key actors of synapse function and plasticity. Prog. Neurobiol. 2010, 91:313-348.
33. Chadman K.K., Gong S., Scattoni M.L., Boltuck S.E., Gandhy S.U., Heintz N., Crawley J.N. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. Off. J. Int. Soc. Autism Res. 2008, 1:147-158.
34. Chang S., Bray S.M., Li Z., Zarnescu D.C., He C., Jin P., Warren S.T. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat. Chem. Biol. 2008, 4:256-263.
35. Chen C.Y., Tsai M.S., Lin C.Y., Yu I.S., Chen Y.T., Lin S.R., Juan L.W., Chen Y.T., Hsu H.M., Lee L.J., Lin S.W. Rescue of the genetically engineered Cul4b mutant mouse as a potential model for human X-linked mental retardation. Hum. Mol. Genet. 2012, 21:4270-4285.
36. Chi P., Greengard P., Ryan T.A. Synapsin dispersion and reclustering during synaptic activity. Nat. Neurosci. 2001, 4:1187-1193.
37. Chi P., Greengard P., Ryan T.A. Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 2003, 38:69-78.
38. Chiappalone M., Casagrande S., Tedesco M., Valtorta F., Baldelli P., Martinoia S., Benfenati F. Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb. Cortex 2009, 19:1422-1439.
39. Chih B., Engelman H., Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 2005, 307:1324-1328.
40. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., Sudhof T.C. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
41. Clement J.P., Aceti M., Creson T.K., Ozkan E.D., Shi Y., Reish N.J., Almonte A.G., Miller B.H., Wiltgen B.J., Miller C.A., Xu X., Rumbaugh G. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 2012, 151:709-723.
42. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5401-5404.
43. Cristino A.S., Williams S.M., Hawi Z., An J.Y., Bellgrove M.A., Schwartz C.E., Costa L.D., Claudianos C. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol. Psychiatry 2014, 19:294-301.
44. D'Arca D., Zhao X., Xu W., Ramirez-Martinez N.C., Iavarone A., Lasorella A. Huwe1 ubiquitin ligase is essential to synchronize neuronal and glial differentiation in the developing cerebellum. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5875-5880.
45. D'Souza-Schorey C., Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol Cell Biol 2006, 7:347-358.
46. Delorme R., Ey E., Toro R., Leboyer M., Gillberg C., Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat. Med. 2013, 19:685-694.
47. Dent E.W., Merriam E.B., Hu X. The dynamic cytoskeleton: backbone of dendritic spine plasticity. Curr. Opin. Neurobiol. 2011, 21:175-181.
48. Dindot S.V., Antalffy B.A., Bhattacharjee M.B., Beaudet A.L. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 2008, 17:111-118.
49. Dölen G., Carpenter R.L., Ocain T.D., Bear M.F. Mechanism-based approaches to treating fragile X. Pharmacol. Ther. 2010, 127:78-93.
50. Du H., Huang Y., Zaghlula M., Walters E., Cox T.C., Massiah M.A. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (alpha4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A. J. Biol. Chem. 2013, 288:21341-21350.
51. Dubos A., Combeau G., Bernardinelli Y., Barnier J.V., Hartley O., Gaertner H., Boda B., Muller D. Alteration of synaptic network dynamics by the intellectual disability protein PAK3. J. Neurosci. 2012, 32:519-527.
52. Dudanova I., Tabuchi K., Rohlmann A., Sudhof T.C., Missler M. Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J. Comp. Neurol. 2007, 502:261-274.
53. Durand C.M., Perroy J., Loll F., Perrais D., Fagni L., Bourgeron T., Montcouquiol M., Sans N. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol. Psychiatry 2012, 17:71-84.
54. Ebert D.H., Greenberg M.E. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013, 493:327-337.
55. Edwards D.C., Sanders L.C., Bokoch G.M., Gill G.N. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1999, 1:253-259.
56. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 2003, 6:231-242.
57. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., Ramesh V., Silva A.J. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat. Med. 2008, 14:843-848.
58. Falivelli G., De Jaco A., Favaloro F.L., Kim H., Wilson J., Dubi N., Ellisman M.H., Abrahams B.S., Taylor P., Comoletti D. Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation. Hum. Mol. Genet. 2012, 21:4761-4773.
59. Fassio A., Patry L., Congia S., Onofri F., Piton A., Gauthier J., Pozzi D., Messa M., Defranchi E., Fadda M., Corradi A., Baldelli P., Lapointe L., St-Onge J., Meloche C., Mottron L., Valtorta F., Khoa Nguyen D., Rouleau G.A., Benfenati F., Cossette P. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum. Mol. Genet. 2011, 20:2297-2307.
60. Fifkova E., Delay R.J. Cytoplasmic actin in neuronal processes as a possible mediator of synaptic plasticity. J. Cell Biol. 1982, 95:345-350.
61. Flex E., Ciolfi A., Caputo V., Fodale V., Leoni C., Melis D., Bedeschi M.F., Mazzanti L., Pizzuti A., Tartaglia M., Zampino G. Loss of function of the E3 ubiquitin-protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome. J. Med. Genet. 2013, 50:493-499.
62. Fornasiero E.F., Raimondi A., Guarnieri F.C., Orlando M., Fesce R., Benfenati F., Valtorta F. Synapsins contribute to the dynamic spatial organization of synaptic vesicles in an activity-dependent manner. J. Neurosci. 2012, 32:12214-12227.
63. Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O., Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H., Chelly J., Sanlaville D., van Bokhoven H., Ropers H.H., Laumonnier F., Ranieri E., Schwartz C.E., Abidi F., Tarpey P.S., Futreal P.A., Whibley A., Raymond F.L., Stratton M.R., Fryns J.P., Scott R., Peippo M., Sipponen M., Partington M., Mowat D., Field M., Hackett A., Marynen P., Turner G., Gecz J. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am. J. Hum. Genet. 2008, 82:432-443.
64. 2+-channel and neurite elongation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9063-9068.
65. Giannandrea M., Bianchi V., Mignogna M.L., Sirri A., Carrabino S., D'Elia E., Vecellio M., Russo S., Cogliati F., Larizza L., Ropers H.H., Tzschach A., Kalscheuer V., Oehl-Jaschkowitz B., Skinner C., Schwartz C.E., Gecz J., Van Esch H., Raynaud M., Chelly J., de Brouwer A.P., Toniolo D., D'Adamo P. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am. J. Hum. Genet. 2010, 86:185-195.
66. Giannandrea M., Guarnieri F.C., Gehring N.H., Monzani E., Benfenati F., Kulozik A.E., Valtorta F. Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356x mutation in synapsin I. PLoS ONE 2013, 8:e67724.
67. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
68. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., Imielinski M., Frackelton E.C., Reichert J., Crawford E.L., Munson J., Sleiman P.M., Chiavacci R., Annaiah K., Thomas K., Hou C., Glaberson W., Flory J., Otieno F., Garris M., Soorya L., Klei L., Piven J., Meyer K.J., Anagnostou E., Sakurai T., Game R.M., Rudd D.S., Zurawiecki D., McDougle C.J., Davis L.K., Miller J., Posey D.J., Michaels S., Kolevzon A., Silverman J.M., Bernier R., Levy S.E., Schultz R.T., Dawson G., Owley T., McMahon W.M., Wassink T.H., Sweeney J.A., Nurnberger J.I., Coon H., Sutcliffe J.S., Minshew N.J., Grant S.F., Bucan M., Cook E.H., Buxbaum J.D., Devlin B., Schellenberg G.D., Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
69. Glyvuk N., Tsytsyura Y., Geumann C., D'Hooge R., Huve J., Kratzke M., Baltes J., Boening D., Klingauf J., Schu P. AP-1/sigma1B-adaptin mediates endosomal synaptic vesicle recycling, learning and memory. EMBO J. 2010, 29:1318-1330.
70. Govek E.E., Newey S.E., Akerman C.J., Cross J.R., Van der Veken L., Van Aelst L. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 2004, 7:364-372.
71. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
72. Grant B.D., Donaldson J.G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2009, 10:597-608.
73. Greco B., Manago F., Tucci V., Kao H.T., Valtorta F., Benfenati F. Autism-related behavioral abnormalities in synapsin knockout mice. Behav. Brain Res. 2013, 251:65-74.
74. Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W., Kim T.K., Griffith E.C., Waldon Z., Maehr R., Ploegh H.L., Chowdhury S., Worley P.F., Steen J., Greenberg M.E. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 2010, 140:704-716.
75. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
76. Hackett A., Tarpey P.S., Licata A., Cox J., Whibley A., Boyle J., Rogers C., Grigg J., Partington M., Stevenson R.E., Tolmie J., Yates J.R., Turner G., Wilson M., Futreal A.P., Corbett M., Shaw M., Gecz J., Raymond F.L., Stratton M.R., Schwartz C.E., Abidi F.E. CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes. Eur. J. Hum. Genet. 2010, 18:544-552.
77. Haddad D.M., Vilain S., Vos M., Esposito G., Matta S., Kalscheuer V.M., Craessaerts K., Leyssen M., Nascimento R.M., Vianna-Morgante A.M., De Strooper B., Van Esch H., Morais V.A., Verstreken P. Mutations in the intellectual disability gene Ube2a cause neuronal dysfunction and impair parkin-dependent mitophagy. Mol. Cell 2013, 50:831-843.
78. Hamdan F.F., Gauthier J., Araki Y., Lin D.T., Yoshizawa Y., Higashi K., Park A.R., Spiegelman D., Dobrzeniecka S., Piton A., Tomitori H., Daoud H., Massicotte C., Henrion E., Diallo O., Group S.D., Shekarabi M., Marineau C., Shevell M., Maranda B., Mitchell G., Nadeau A., D'Anjou G., Vanasse M., Srour M., Lafreniere R.G., Drapeau P., Lacaille J.C., Kim E., Lee J.R., Igarashi K., Huganir R.L., Rouleau G.A., Michaud J.L. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am. J. Hum. Genet. 2011, 88:306-316.
79. Hayashi T., Yoshida T., Ra M., Taguchi R., Mishina M. IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway. PLoS ONE 2013, 8:e66254.
80. Ho V.M., Lee J.A., Martin K.C. The cell biology of synaptic plasticity. Science 2011, 334:623-628.
81. Holtmaat A., Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009, 10:647-658.
82. Hoogenraad C.C., Bradke F. Control of neuronal polarity and plasticity - a renaissance for microtubules?. Trends Cell Biol. 2009, 19:669-676.
83. Hotulainen P., Hoogenraad C.C. Actin in dendritic spines: connecting dynamics to function. J. Cell Biol. 2010, 189:619-629.
84. Hsueh Y.P. The role of the MAGUK protein CASK in neural development and synaptic function. Curr. Med. Chem. 2006, 13:1915-1927.
85. Huang H.S., Allen J.A., Mabb A.M., King I.F., Miriyala J., Taylor-Blake B., Sciaky N., Dutton J.W., Lee H.M., Chen X., Jin J., Bridges A.S., Zylka M.J., Roth B.L., Philpot B.D. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 2011, 481:185-189.
86. Humeau Y., Gambino F., Chelly J., Vitale N. X-linked mental retardation: focus on synaptic function and plasticity. J. Neurochem. 2009, 109:1-14.
87. Hutsler J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 2010, 1309:83-94.
88. Huttenlocher P.R. Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology 1974, 24:203-210.
89. Hwang C.S., Sukalo M., Batygin O., Addor M.C., Brunner H., Aytes A.P., Mayerle J., Song H.K., Varshavsky A., Zenker M. Ubiquitin ligases of the N-end rule pathway: assessment of mutations in UBR1 that cause the Johanson-Blizzard syndrome. PLoS ONE 2011, 6:e24925.
90. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., Kooy F., Willems P.J., Cras P., Kozlowski P.B., Swain R.A., Weiler I.J., Greenough W.T. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet. 2001, 98:161-167.
91. Isrie M., Kalscheuer V.M., Holvoet M., Fieremans N., Van Esch H., Devriendt K. HUWE1 mutation explains phenotypic severity in a case of familial idiopathic intellectual disability. Eur. J. Med. Genet. 2013, 56:379-382.
92. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T., Paris Autism Research International Sibpair S. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
93. Jan Y.N., Jan L.Y. Branching out: mechanisms of dendritic arborization. Nat. Rev. Neurosci. 2010, 11:316-328.
94. Jaworski J., Spangler S., Seeburg D.P., Hoogenraad C.C., Sheng M. Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci. 2005, 25:11300-11312.
95. Jiang B., Zhao W., Yuan J., Qian Y., Sun W., Zou Y., Guo C., Chen B., Shao C., Gong Y. Lack of Cul4b, an E3 ubiquitin ligase component, leads to embryonic lethality and abnormal placental development. PLoS ONE 2012, 7:e37070.
96. Jiang Y.H., Yuen R.K., Jin X., Wang M., Chen N., Wu X., Ju J., Mei J., Shi Y., He M., Wang G., Liang J., Wang Z., Cao D., Carter M.T., Chrysler C., Drmic I.E., Howe J.L., Lau L., Marshall C.R., Merico D., Nalpathamkalam T., Thiruvahindrapuram B., Thompson A., Uddin M., Walker S., Luo J., Anagnostou E., Zwaigenbaum L., Ring R.H., Wang J., Lajonchere C., Wang J., Shih A., Szatmari P., Yang H., Dawson G., Li Y., Scherer S.W. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 2013, 93:249-263.
97. Jolly L.A., Homan C.C., Jacob R., Barry S., Gecz J. The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Hum. Mol. Genet. 2013, 22:4673-4687.
98. Kaufman L., Ayub M., Vincent J.B. The genetic basis of non-syndromic intellectual disability: a review. J. Neurodev. Disord. 2010, 2:182-209.
99. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 2000, 10:981-991.
100. Kerzendorfer C., Whibley A., Carpenter G., Outwin E., Chiang S.C., Turner G., Schwartz C., El-Khamisy S., Raymond F.L., O'Driscoll M. Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks. Hum. Mol. Genet. 2010, 19:1324-1334.
101. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., Gusella J.F. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:199-207.
102. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 1997, 15:70-73.
103. Kneussel M., Brandstatter J.H., Gasnier B., Feng G., Sanes J.R., Betz H. Gephyrin-independent clustering of postsynaptic GABA(A) receptor subtypes. Mol. Cell. Neurosci. 2001, 17:973-982.
104. Kneussel M., Engelkamp D., Betz H. Distribution of transcripts for the brain-specific GDP/GTP exchange factor collybistin in the developing mouse brain. Eur. J. Neurosci. 2001, 13:487-492.
105. Kong X.F., Bousfiha A., Rouissi A., Itan Y., Abhyankar A., Bryant V., Okada S., Ailal F., Bustamante J., Casanova J.L., Hirst J., Boisson-Dupuis S. A novel homozygous p.R1105X mutation of the AP4E1 gene in twins with hereditary spastic paraplegia and mycobacterial disease. PLoS ONE 2013, 8:e58286.
106. Korber C., Richter A., Kaiser M., Schlicksupp A., Mukusch S., Kuner T., Kirsch J., Kuhse J. Effects of distinct collybistin isoforms on the formation of GABAergic synapses in hippocampal neurons. Mol. Cell. Neurosci. 2012, 50:250-259.
107. Kou Y., Betancur C., Xu H., Buxbaum J.D., Ma'ayan A. Network- and attribute-based classifiers can prioritize genes and pathways for autism spectrum disorders and intellectual disability. Am. J. Med. Genet. C Semin. Med. Genet. 2012, 160C:130-142.
108. Kramer J.M., Kochinke K., Merel A.W., Oortveld M.A.W., Marks H., Kramer D., de Jong E.K., Asztalos Z., Westwood J.T., Stunnenberg H.G., Sokolowski M.B., Keleman K., Zhou H., van Bokhoven H., Schenck A. Epigenetic regulation of learning and memory by Drosophila EHMT/G9a. PLoS Biol. 2011, 9:e1000569.
109. Kreis P., Thevenot E., Rousseau V., Boda B., Muller D., Barnier J.V. The p21-activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42-dependent pathway. J. Biol. Chem. 2007, 282:21497-21506.
110. Kuhnle S., Mothes B., Matentzoglu K., Scheffner M. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8888-8893.
111. Kumar V., Zhang M.X., Swank M.W., Kunz J., Wu G.Y. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 2005, 25:11288-11299.
112. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., Laudier B., Chelly J., Fryns J.P., Ropers H.H., Hamel B.C., Andres C., Barthelemy C., Moraine C., Briault S. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
113. Laumonnier F., Shoubridge C., Antar C., Nguyen L.S., Van Esch H., Kleefstra T., Briault S., Fryns J.P., Hamel B., Chelly J., Ropers H.H., Ronce N., Blesson S., Moraine C., Gécz J., Raynaud M. Mutations of the UPF3B gene, which encodes a protein widely expressed in neurons, are associated with nonspecific mental retardation with or without autism. Mol. Psychiatry 2010, 15:767-776.
114. Lehman N.L. The ubiquitin proteasome system in neuropathology. Acta Neuropathol. (Berl.) 2009, 118:329-347.
115. Liu L., Sabo A., Neale B.M., Nagaswamy U., Stevens C., Lim E., Bodea C.A., Muzny D., Reid J.G., Banks E., Coon H., Depristo M., Dinh H., Fennel T., Flannick J., Gabriel S., Garimella K., Gross S., Hawes A., Lewis L., Makarov V., Maguire J., Newsham I., Poplin R., Ripke S., Shakir K., Samocha K.E., Wu Y., Boerwinkle E., Buxbaum J.D., Cook E.H., Devlin B., Schellenberg G.D., Sutcliffe J.S., Daly M.J., Gibbs R.A., Roeder K. Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet. 2013, 9:e1003443.
116. Mabb A.M., Ehlers M.D. Ubiquitination in postsynaptic function and plasticity. Annu. Rev. Cell Dev. Biol. 2010, 26:179-210.
117. Matsuura T., Sutcliffe J.S., Fang P., Galjaard R.J., Jiang Y.H., Benton C.S., Rommens J.M., Beaudet A.L. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 1997, 15:74-77.
118. Matus A. Actin-based plasticity in dendritic spines. Science 2000, 290:754-758.
119. Matus A., Ackermann M., Pehling G., Byers H.R., Fujiwara K. High actin concentrations in brain dendritic spines and postsynaptic densities. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:7590-7594.
120. Mefford H.C., Batshaw M.L., Hoffman E.P. Genomics, intellectual disability, and autism. N. Engl. J. Med. 2012, 366:733-743.
121. Meng J., Meng Y., Hanna A., Janus C., Jia Z. Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J. Neurosci. 2005, 25:6641-6650.
122. Meng Y., Zhang Y., Tregoubov V., Janus C., Cruz L., Jackson M., Lu W.Y., MacDonald J.F., Wang J.Y., Falls D.L., Jia Z. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002, 35:121-133.
123. Milh M., Villeneuve N., Chouchane M., Kaminska A., Laroche C., Barthez M.A., Gitiaux C., Bartoli C., Borges-Correia A., Cacciagli P., Mignon-Ravix C., Cuberos H., Chabrol B., Villard L. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia 2011, 52:1828-1834.
124. Missler M., Sudhof T.C., Biederer T. Synaptic cell adhesion. Cold Spring Harb. Perspect. Biol. 2012, 4:a005694.
125. 2+ channels to synaptic vesicle exocytosis. Nature 2003, 423:939-948.
126. Moreno-De-Luca A., Helmers S.L., Mao H., Burns T.G., Melton A.M., Schmidt K.R., Fernhoff P.M., Ledbetter D.H., Martin C.L. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J. Med. Genet. 2011, 48:141-144.
127. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., Mukaddes N.M., Balkhy S., Gascon G., Hashmi A., Al-Saad S., Ware J., Joseph R.M., Greenblatt R., Gleason D., Ertelt J.A., Apse K.A., Bodell A., Partlow J.N., Barry B., Yao H., Markianos K., Ferland R.J., Greenberg M.E., Walsh C.A. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
128. Nadif Kasri N., Nakano-Kobayashi A., Malinow R., Li B., Van Aelst L. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 2009, 23:1289-1302.
129. Najm J., Horn D., Wimplinger I., Golden J.A., Chizhikov V.V., Sudi J., Christian S.L., Ullmann R., Kuechler A., Haas C.A., Flubacher A., Charnas L.R., Uyanik G., Frank U., Klopocki E., Dobyns W.B., Kutsche K. Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum. Nat. Genet. 2008, 40:1065-1067.
130. Nakagawa T., Xiong Y. X-linked mental retardation gene CUL4B targets ubiquitylation of H3K4 methyltransferase component WDR5 and regulates neuronal gene expression. Mol. Cell 2011, 43:381-391.
131. Nakano-Kobayashi A., Kasri N.N., Newey S.E., Van Aelst L. The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1. Curr. Biol. 2009, 19:1133-1139.
132. Nam C.I., Chen L. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6137-6142.
133. Nascimento R.M., Otto P.A., de Brouwer A.P., Vianna-Morgante A.M. UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. Am. J. Hum. Genet. 2006, 79:549-555.
134. Newschaffer C.J., Croen L.A., Daniels J., Giarelli E., Grether J.K., Levy S.E., Mandell D.S., Miller L.A., Pinto-Martin J., Reaven J., Reynolds A.M., Rice C.E., Schendel D., Windham G.C. The epidemiology of autism spectrum disorders. Annu. Rev. Publ. Health 2007, 28:235-258.
135. Nguyen L.S., Jolly L., Shoubridge C., Chan W.K., Huang L., Laumonnier F., Raynaud M., Hackett A., Field M., Rodriguez J., Srivastava A.K., Lee Y., Long R., Addington A.M., Rapoport J.L., Suren S., Hahn C.N., Gamble J., Wilkinson M.F., Corbett M.A., Gecz J. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol. Psychiatry 2012, 17:1103-1115.
136. Nguyen L.S., Wilkinson M., Gecz J. Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci. Biobehav. Rev. 2013, pii: S0149-7634(13)00270-4.
137. Nguyen L.S., Kim H.G., Rosenfeld J.A., Shen Y., Gusella J.F., Lacassie Y., Layman L.C., Shaffer L.G., Gécz J. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders. Hum. Mol. Genet. 2013, 22:1816-1825.
138. Node-Langlois R., Muller D., Boda B. Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis. J. Cell Sci. 2006, 119:4986-4993.
139. Noor A., Whibley A., Marshall C.R., Gianakopoulos P.J., Piton A., Carson A.R., Orlic-Milacic M., Lionel A.C., Sato D., Pinto D., Drmic I., Noakes C., Senman L., Zhang X., Mo R., Gauthier J., Crosbie J., Pagnamenta A.T., Munson J., Estes A.M., Fiebig A., Franke A., Schreiber S., Stewart A.F., Roberts R., McPherson R., Guter S.J., Cook E.H., Dawson G., Schellenberg G.D., Battaglia A., Maestrini E., Autism Genome Project C., Jeng L., Hutchison T., Rajcan-Separovic E., Chudley A.E., Lewis S.M., Liu X., Holden J.J., Fernandez B., Zwaigenbaum L., Bryson S.E., Roberts W., Szatmari P., Gallagher L., Stratton M.R., Gecz J., Brady A.F., Schwartz C.E., Schachar R.J., Monaco A.P., Rouleau G.A., Hui C.C., Lucy Raymond F., Scherer S.W., Vincent J.B. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci. Transl. Med. 2010, 2:49ra68.
140. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B., Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E., Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
141. Okamoto K., Nagai T., Miyawaki A., Hayashi Y. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat. Neurosci. 2004, 7:1104-1112.
142. Orenbuch A., Shalev L., Marra V., Sinai I., Lavy Y., Kahn J., Burden J.J., Staras K., Gitler D. Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals. J. Neurosci. 2012, 32:3969-3980.
143. Pagnamenta A.T., Khan H., Walker S., Gerrelli D., Wing K., Bonaglia M.C., Giorda R., Berney T., Mani E., Molteni M., Pinto D., Le Couteur A., Hallmayer J., Sutcliffe J.S., Szatmari P., Paterson A.D., Scherer S.W., Vieland V.J., Monaco A.P. Rare familial 16q21 microdeletions under a linkage peak implicate cadherin 8 (CDH8) in susceptibility to autism and learning disability. J. Med. Genet. 2011, 48:48-54.
144. Papadopoulos T., Korte M., Eulenburg V., Kubota H., Retiounskaia M., Harvey R.J., Harvey K., O'Sullivan G.A., Laube B., Hulsmann S., Geiger J.R., Betz H. Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J. 2007, 26:3888-3899.
145. Pavlowsky A., Gianfelice A., Pallotto M., Zanchi A., Vara H., Khelfaoui M., Valnegri P., Rezai X., Bassani S., Brambilla D., Kumpost J., Blahos J., Roux M.J., Humeau Y., Chelly J., Passafaro M., Giustetto M., Billuart P., Sala C. A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Curr. Biol. 2010, 20:103-115.
146. Pavlowsky A., Zanchi A., Pallotto M., Giustetto M., Chelly J., Sala C., Billuart P. Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions. Commun. Integr. Biol. 2010, 3:245-247.
147. Perou R., Bitsko R.H., Blumberg S.J., Pastor P., Ghandour R.M., Gfroerer J.C., Hedden S.L., Crosby A.E., Visser S.N., Schieve L.A., Parks S.E., Hall J.E., Brody D., Simile C.M., Thompson W.W., Baio J., Avenevoli S., Kogan M.D., Huang L.N. Mental health surveillance among children - United States, 2005-2011. Morbid. Mortal. Week. Rep. 2013, 62(Suppl. 2):1-35. Surveillance summaries (Washington, DC, 2002).
148. Pevsner J., Hsu S.C., Scheller R.H. n-Sec1: a neural-specific syntaxin-binding protein. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1445-1449.
149. Pfeiffer B.E., Zang T., Wilkerson J.R., Taniguchi M., Maksimova M.A., Smith L.N., Cowan C.W., Huber K.M. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 2010, 66:191-197.
150. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Almeida J., Bacchelli E., Bader G.D., Bailey A.J., Baird G., Battaglia A., Berney T., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Bryson S.E., Carson A.R., Casallo G., Casey J., Chung B.H., Cochrane L., Corsello C., Crawford E.L., Crossett A., Cytrynbaum C., Dawson G., de Jonge M., Delorme R., Drmic I., Duketis E., Duque F., Estes A., Farrar P., Fernandez B.A., Folstein S.E., Fombonne E., Freitag C.M., Gilbert J., Gillberg C., Glessner J.T., Goldberg J., Green A., Green J., Guter S.J., Hakonarson H., Heron E.A., Hill M., Holt R., Howe J.L., Hughes G., Hus V., Igliozzi R., Kim C., Klauck S.M., Kolevzon A., Korvatska O., Kustanovich V., Lajonchere C.M., Lamb J.A., Laskawiec M., Leboyer M., Le Couteur A., Leventhal B.L., Lionel A.C., Liu X.Q., Lord C., Lotspeich L., Lund S.C., Maestrini E., Mahoney W., Mantoulan C., Marshall C.R., McConachie H., McDougle C.J., McGrath J., McMahon W.M., Merikangas A., Migita O., Minshew N.J., Mirza G.K., Munson J., Nelson S.F., Noakes C., Noor A., Nygren G., Oliveira G., Papanikolaou K., Parr J.R., Parrini B., Paton T., Pickles A., Pilorge M., Piven J., Ponting C.P., Posey D.J., Poustka A., Poustka F., Prasad A., Ragoussis J., Renshaw K., Rickaby J., Roberts W., Roeder K., Roge B., Rutter M.L., Bierut L.J., Rice J.P., Salt J., Sansom K., Sato D., Segurado R., Sequeira A.F., Senman L., Shah N., Sheffield V.C., Soorya L., Sousa I., Stein O., Sykes N., Stoppioni V., Strawbridge C., Tancredi R., Tansey K., Thiruvahindrapduram B., Thompson A.P., Thomson S., Tryfon A., Tsiantis J., Van Engeland H., Vincent J.B., Volkmar F., Wallace S., Wang K., Wang Z., Wassink T.H., Webber C., Weksberg R., Wing K., Wittemeyer K., Wood S., Wu J., Yaspan B.L., Zurawiecki D., Zwaigenbaum L., Buxbaum J.D., Cantor R.M., Cook E.H., Coon H., Cuccaro M.L., Devlin B., Ennis S., Gallagher L., Geschwind D.H., Gill M., Haines J.L., Hallmayer J., Miller J., Monaco A.P., Nurnberger J.I., Paterson A.D., Pericak-Vance M.A., Schellenberg G.D., Szatmari P., Vicente A.M., Vieland V.J., Wijsman E.M., Scherer S.W., Sutcliffe J.S., Betancur C. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
151. Piton A., Gauthier J., Hamdan F.F., Lafreniere R.G., Yang Y., Henrion E., Laurent S., Noreau A., Thibodeau P., Karemera L., Spiegelman D., Kuku F., Duguay J., Destroismaisons L., Jolivet P., Cote M., Lachapelle K., Diallo O., Raymond A., Marineau C., Champagne N., Xiong L., Gaspar C., Riviere J.B., Tarabeux J., Cossette P., Krebs M.O., Rapoport J.L., Addington A., Delisi L.E., Mottron L., Joober R., Fombonne E., Drapeau P., Rouleau G.A. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol. Psychiatry 2011, 16:867-880.
152. Piton A., Michaud J.L., Peng H., Aradhya S., Gauthier J., Mottron L., Champagne N., Lafreniere R.G., Hamdan F.F., team S.D., Joober R., Fombonne E., Marineau C., Cossette P., Dube M.P., Haghighi P., Drapeau P., Barker P.A., Carbonetto S., Rouleau G.A. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 2008, 17:3965-3974.
153. Purpura D.P. Dendritic spine dysgenesis and mental retardation. Science 1974, 186:1126-1128.
154. Raemaekers T., Peric A., Baatsen P., Sannerud R., Declerck I., Baert V., Michiels C., Annaert W. ARF6-mediated endosomal transport of Telencephalin affects dendritic filopodia-to-spine maturation. EMBO J. 2012, 31:3252-3269.
155. Ramakers G.J., Wolfer D., Rosenberger G., Kuchenbecker K., Kreienkamp H.J., Prange-Kiel J., Rune G., Richter K., Langnaese K., Masneuf S., Bosl M.R., Fischer K.D., Krugers H.J., Lipp H.P., van Galen E., Kutsche K. Dysregulation of Rho GTPases in the alphaPix/Arhgef6 mouse model of X-linked intellectual disability is paralleled by impaired structural and synaptic plasticity and cognitive deficits. Hum. Mol. Genet. 2012, 21:268-286.
156. Redies C., Hertel N., Hubner C.A. Cadherins and neuropsychiatric disorders. Brain Res. 2012, 1470:130-144.
157. Reissner C., Klose M., Fairless R., Missler M. Mutational analysis of the neurexin/neuroligin complex reveals essential and regulatory components. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15124-15129.
158. Rex C.S., Gavin C.F., Rubio M.D., Kramar E.A., Chen L.Y., Jia Y., Huganir R.L., Muzyczka N., Gall C.M., Miller C.A., Lynch G., Rumbaugh G. Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation. Neuron 2010, 67:603-617.
159. Robinson M.S. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004, 14:167-174.
160. Rousseau V., Goupille O., Morin N., Barnier J.V. A new constitutively active brain PAK3 isoform displays modified specificities toward Rac and Cdc42 GTPases. J. Biol. Chem. 2003, 278:3912-3920.
161. Salinas G.D., Blair L.A., Needleman L.A., Gonzales J.D., Chen Y., Li M., Singer J.D., Marshall J. Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway. J. Biol. Chem. 2006, 281:40164-40173.
162. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., Mason C.E., Bilguvar K., Celestino-Soper P.B., Choi M., Crawford E.L., Davis L., Wright N.R., Dhodapkar R.M., DiCola M., DiLullo N.M., Fernandez T.V., Fielding-Singh V., Fishman D.O., Frahm S., Garagaloyan R., Goh G.S., Kammela S., Klei L., Lowe J.K., Lund S.C., McGrew A.D., Meyer K.A., Moffat W.J., Murdoch J.D., O'Roak B.J., Ober G.T., Pottenger R.S., Raubeson M.J., Song Y., Wang Q., Yaspan B.L., Yu T.W., Yurkiewicz I.R., Beaudet A.L., Cantor R.M., Curland M., Grice D.E., Gunel M., Lifton R.P., Mane S.M., Martin D.M., Shaw C.A., Sheldon M., Tischfield J.A., Walsh C.A., Morrow E.M., Ledbetter D.H., Fombonne E., Lord C., Martin C.L., Brooks A.I., Sutcliffe J.S., Cook E.H., Geschwind D., Roeder K., Devlin B., State M.W. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
163. Sato D., Lionel A.C., Leblond C.S., Prasad A., Pinto D., Walker S., O'Connor I., Russell C., Drmic I.E., Hamdan F.F., Michaud J.L., Endris V., Roeth R., Delorme R., Huguet G., Leboyer M., Rastam M., Gillberg C., Lathrop M., Stavropoulos D.J., Anagnostou E., Weksberg R., Fombonne E., Zwaigenbaum L., Fernandez B.A., Roberts W., Rappold G.A., Marshall C.R., Bourgeron T., Szatmari P., Scherer S.W. SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Genet. 2012, 90:879-887.
164. Scheiffele P. Cell-cell signaling during synapse formation in the CNS. Annu. Rev. Neurosci. 2003, 26:485-508.
165. Segref A., Hoppe T. Think locally: control of ubiquitin-dependent protein degradation in neurons. EMBO Rep. 2009, 10:44-50.
166. Sharma A., Hoeffer C.A., Takayasu Y., Miyawaki T., McBride S.M., Klann E., Zukin R.S. Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 2010, 30:694-702.
167. Shoubridge C., Tarpey P.S., Abidi F., Ramsden S.L., Rujirabanjerd S., Murphy J.A., Boyle J., Shaw M., Gardner A., Proos A., Puusepp H., Raymond F.L., Schwartz C.E., Stevenson R.E., Turner G., Field M., Walikonis R.S., Harvey R.J., Hackett A., Futreal P.A., Stratton M.R., Gecz J. Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability. Nat. Genet. 2010, 42:486-488.
168. Shoubridge C., Walikonis R.S., Gecz J., Harvey R.J. Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disability. Small GTPases 2010, 1:98-103.
169. Smith S.E., Zhou Y.D., Zhang G., Jin Z., Stoppel D.C., Anderson M.P. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 2011, 3:103ra197.
170. Smyth A.M., Yang L., Martin K.J., Hamilton C., Lu W., Cousin M.A., Rickman C., Duncan R.R. Munc18-1 protein molecules move between membrane molecular depots distinct from vesicle docking sites. J. Biol. Chem. 2013, 288:5102-5113.
171. Sollner T., Bennett M.K., Whiteheart S.W., Scheller R.H., Rothman J.E. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 1993, 75:409-418.
172. Spangler S.A., Schmitz S.K., Kevenaar J.T., de Graaff E., de Wit H., Demmers J., Toonen R.F., Hoogenraad C.C. Liprin-alpha2 promotes the presynaptic recruitment and turnover of RIM1/CASK to facilitate synaptic transmission. J. Cell Biol. 2013, 201:915-928.
173. Sudhof T.C. The synaptic vesicle cycle. Annu. Rev. Neurosci. 2004, 27:509-547.
174. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
175. Sun M., Liu L., Zeng X., Xu M., Liu L., Fang M., Xie W. Genetic interaction between Neurexin and CAKI/CMG is important for synaptic function in Drosophila neuromuscular junction. Neurosci. Res. 2009, 64:362-371.
176. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
177. Tai H.C., Schuman E.M. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat. Rev. Neurosci. 2008, 9:826-838.
178. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 2001, 81:153-208.
179. Tarpey P.S., Raymond F.L., O'Meara S., Edkins S., Teague J., Butler A., Dicks E., Stevens C., Tofts C., Avis T., Barthorpe S., Buck G., Cole J., Gray K., Halliday K., Harrison R., Hills K., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Varian J., West S., Widaa S., Mallya U., Moon J., Luo Y., Holder S., Smithson S.F., Hurst J.A., Clayton-Smith J., Kerr B., Boyle J., Shaw M., Vandeleur L., Rodriguez J., Slaugh R., Easton D.F., Wooster R., Bobrow M., Srivastava A.K., Stevenson R.E., Schwartz C.E., Turner G., Gecz J., Futreal P.A., Stratton M.R., Partington M. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 2007, 80:345-352.
180. Tarpey P.S., Smith R., Pleasance E., Whibley A., Edkins S., Hardy C., O'Meara S., Latimer C., Dicks E., Menzies A., Stephens P., Blow M., Greenman C., Xue Y., Tyler-Smith C., Thompson D., Gray K., Andrews J., Barthorpe S., Buck G., Cole J., Dunmore R., Jones D., Maddison M., Mironenko T., Turner R., Turrell K., Varian J., West S., Widaa S., Wray P., Teague J., Butler A., Jenkinson A., Jia M., Richardson D., Shepherd R., Wooster R., Tejada M.I., Martinez F., Carvill G., Goliath R., de Brouwer A.P., van Bokhoven H., Van Esch H., Chelly J., Raynaud M., Ropers H.H., Abidi F.E., Srivastava A.K., Cox J., Luo Y., Mallya U., Moon J., Parnau J., Mohammed S., Tolmie J.L., Shoubridge C., Corbett M., Gardner A., Haan E., Rujirabanjerd S., Shaw M., Vandeleur L., Fullston T., Easton D.F., Boyle J., Partington M., Hackett A., Field M., Skinner C., Stevenson R.E., Bobrow M., Turner G., Schwartz C.E., Gecz J., Raymond F.L., Futreal P.A., Stratton M.R. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat. Genet. 2009, 41:535-543.
181. Tsai N.P., Wilkerson J.R., Guo W., Maksimova M.A., DeMartino G.N., Cowan C.W., Huber K.M. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 2012, 151:1581-1594.
182. Tyagarajan S.K., Ghosh H., Harvey K., Fritschy J.M. Collybistin splice variants differentially interact with gephyrin and Cdc42 to regulate gephyrin clustering at GABAergic synapses. J. Cell Sci. 2011, 124:2786-2796.
183. Valnegri P., Sala C., Passafaro M. Synaptic dysfunction and intellectual disability. Adv. Exp. Med. Biol. 2012, 970:433-449.
184. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 2011, 45:81-104.
185. van Woerden G.M., Harris K.D., Hojjati M.R., Gustin R.M., Qiu S., de Avila Freire R., Jiang Y.H., Elgersma Y., Weeber E.J. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat. Neurosci. 2007, 10:280-282.
186. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., Zhang W., Sudhof T.C., Brose N. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
187. Vincent A.K., Noor A., Janson A., Minassian B.A., Ayub M., Vincent J.B., Morel C.F. Identification of genomic deletions spanning the PCDH19 gene in two unrelated girls with intellectual disability and seizures. Clin. Genet. 2012, 82:540-545.
188. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
189. Waites C.L., Garner C.C. Presynaptic function in health and disease. Trends Neurosci. 2011, 34:326-337.
190. Wang H.L., Chang N.C., Weng Y.H., Yeh T.H. XLID CUL4B mutants are defective in promoting TSC2 degradation and positively regulating mTOR signaling in neocortical neurons. Biochim. Biophys. Acta 2013, 1832:585-593.
191. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., Kim C.E., Hou C., Frackelton E., Chiavacci R., Takahashi N., Sakurai T., Rappaport E., Lajonchere C.M., Munson J., Estes A., Korvatska O., Piven J., Sonnenblick L.I., Alvarez Retuerto A.I., Herman E.I., Dong H., Hutman T., Sigman M., Ozonoff S., Klin A., Owley T., Sweeney J.A., Brune C.W., Cantor R.M., Bernier R., Gilbert J.R., Cuccaro M.L., McMahon W.M., Miller J., State M.W., Wassink T.H., Coon H., Levy S.E., Schultz R.T., Nurnberger J.I., Haines J.L., Sutcliffe J.S., Cook E.H., Minshew N.J., Buxbaum J.D., Dawson G., Grant S.F., Geschwind D.H., Pericak-Vance M.A., Schellenberg G.D., Hakonarson H. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
192. Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C., Kim C.J., Berrios J., Colvin J.S., Bousquet-Moore D., Lorenzo I., Wu G., Weinberg R.J., Ehlers M.D., Philpot B.D., Beaudet A.L., Wetsel W.C., Jiang Y.H. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 2011, 20:3093-3108.
193. West A.E., Greenberg M.E. Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb. Perspect. Biol. 2011, 3. pii: a005744.
194. Wilkins J., Matson J.L. A comparison of social skills profiles in intellectually disabled adults with and without ASD. Behav. Modif. 2009, 33:143-155.
195. Yashiro K., Riday T.T., Condon K.H., Roberts A.C., Bernardo D.R., Prakash R., Weinberg R.J., Ehlers M.D., Philpot B.D. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 2009, 12:777-783.
196. Yoshida T., Yasumura M., Uemura T., Lee S.J., Ra M., Taguchi R., Iwakura Y., Mishina M. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta. J. Neurosci. 2011, 31:13485-13499.
197. Zenker M., Mayerle J., Lerch M.M., Tagariello A., Zerres K., Durie P.R., Beier M., Hulskamp G., Guzman C., Rehder H., Beemer F.A., Hamel B., Vanlieferinghen P., Gershoni-Baruch R., Vieira M.W., Dumic M., Auslender R., Gil-da-Silva-Lopes V.L., Steinlicht S., Rauh M., Shalev S.A., Thiel C., Ekici A.B., Winterpacht A., Kwon Y.T., Varshavsky A., Reis A. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat. Genet. 2005, 37:1345-1350.
198. Zhang C., Atasoy D., Arac D., Yang X., Fucillo M.V., Robison A.J., Ko J., Brunger A.T., Sudhof T.C. Neurexins physically and functionally interact with GABA(A) receptors. Neuron 2010, 66:403-416.
199. Zhou P., Pang Z.P., Yang X., Zhang Y., Rosenmund C., Bacaj T., Sudhof T.C. Syntaxin-1 N-peptide and Habc-domain perform distinct essential functions in synaptic vesicle fusion. EMBO J. 2013, 32:159-171.
200. Zou Y., Liu Q., Chen B., Zhang X., Guo C., Zhou H., Li J., Gao G., Guo Y., Yan C., Wei J., Shao C., Gong Y. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 2007, 80:561-566.
201. Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B., Collins A.L., Bijlsma E.K., Oortveld M.A., Ekici A.B., Reis A., Schenck A., Rauch A. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am. J. Hum. Genet. 2009, 85:655-666.